Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HRB✓SelectedUSD · HRBGSK vs HRB performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs HRB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
HRB return
+122.2%
Excess return
-81.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioHRBExcessAlpha
1D-0.1%-0.9%+0.8%-0.1%
7D-5.3%-8.0%+2.7%-4.9%
30D-3.7%-3.8%+0.1%-3.4%
3M-7.3%-12.5%+5.2%-6.6%
6M-4.2%+17.9%-22.2%-5.2%
YTD+0.9%+9.2%-8.3%+0.8%
1Y+7.3%+10.9%-3.6%+7.0%
3Y+52.7%+10.3%+42.4%+52.9%
All+41.1%+122.2%-81.1%+38.8%

Cumulative growth

Daily Returns

Daily percentage return beside HRB.

Daily Out/Under-Performance

Portfolio return minus HRB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HRB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded HRB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling